Navigation Links
Regulus Reports Third Quarter 2013 Financial Results and Recent Highlights
Date:11/13/2013

Option Agreement with Sanofi. At the ASN Kidney Week 2013 meeting, Regulus and its strategic alliance partner, Sanofi, and its collaborator at the University of Washington, presented positive preclinical data in a poster and oral presentations demonstrating that miR-21 plays an important role in the disease progression of Alport Syndrome in collagen 4A3 deficient mice. According to the National Institutes of Health, Alport Syndrome occurs in approximately 1 in 50,000 newborns. Alport Syndrome is a genetic condition characterized by kidney disease, hearing loss, and eye abnormalities. The kidneys become less able to function as this condition progresses, resulting in end-stage renal disease. These results demonstrate that treatment with an anti-miR-21 candidate significantly improved renal function, significantly reversed regulated genes and pathways associated with renal pathology, and increased the lifespan of the mice by 20 percent.
Regulus and Sanofi entered into an Option Agreement to enable exclusive negotiation of a potential new co-development and commercialization agreement. Under the terms of the Option Agreement, Regulus has the exclusive right to negotiate with Sanofi to enter into a co-development and commercialization agreement for certain miR-21 anti-miRs in oncology and in Alport Syndrome. Regulus anticipates that the second microRNA candidate to be nominated for clinical development by the end of the year under its 'Road to the Clinic' strategy may come from the miR-21 fibrosis program.
  • Achieved Significant Progress in Strategic Alliance with AstraZeneca; New Pre-Clinically Validated microRNA Oncology Target Selected. Under Regulus' strategic alliance to discover, develop, and commercialize microRNA therapeutics with AstraZeneca, an undisclosed, pre-clinically validated oncology target was selected by AstraZeneca. The companies continue to collaborate on three exclusive microRNA targets in cardiovascular and metabolic
    '/>"/>

  • SOURCE Regulus Therapeutics Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related medicine technology :

    1. Regulus Presents Positive Preclinical Data Demonstrating that microRNA-21 Plays an Important Role in Alport Syndrome
    2. Regulus Announces Timing for Third Quarter 2013 Financial Results Webcast and Conference Call
    3. Regulus Announces Significant Progress in Strategic Alliance with AstraZeneca and Selection of a New Pre-Clinically Validated microRNA Oncology Target
    4. Regulus Reports Second Quarter 2013 Financial Results and Recent Highlights
    5. Regulus Announces Timing for Second Quarter 2013 Financial Results Webcast and Conference Call
    6. Regulus Names Stelios Papadopoulos, Ph.D. as Chairman of its Board of Directors
    7. Regulus to Present at Deutsche Bank 38th Annual Healthcare Conference
    8. Regulus Provides Update on Road to the Clinic Strategy and Reports First Quarter 2013 Financial Results and Recent Highlights
    9. Regulus Announces Timing for First Quarter 2013 Financial Results Webcast and Conference Call
    10. Regulus Appoints William H. Rastetter, Ph.D. to its Board of Directors
    11. Regulus to Present at Future Leaders in the Biotech Industry Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/30/2015)... EDINBURGH, Scotland , July 1, 2015 ... joins Nu C ana team   ... proprietary ProTide technology to develop and commercialise a portfolio ... Professor Chris McGuigan as Chief Scientific Officer. ... the ProTide technology. He is currently Professor of Medicinal ...
    (Date:6/30/2015)... 2015 Ansell, a global leader ... of the first Ansell Cares ® H.E.R.O. ... The 2015 award, organised in partnership with the European ... display exceptional skill and quality in patient care, and ... Award ceremonies are taking place today in the winners, ...
    (Date:6/30/2015)... Calif. , June 30, 2015  The MEDevice ... consecutive year, is an event dedicated to bringing medtech ... hottest issues and topics affecting the industry today. This ... address the challenges and opportunities facing today,s medtech professional ... information and to register for MEDevice San Diego, please ...
    Breaking Medicine Technology:Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 2Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 3Ansell Announces European O.R. Nurse Hero Award Winners 2Ansell Announces European O.R. Nurse Hero Award Winners 3MEDevice San Diego 2015 Attracts High-Tech Medical Industry 2
    ... ROCKVILLE, Md., Feb. 18, 2011 Novavax, Inc. ... today presented the final safety and immunogenicity results from ... clinical trial in Mexico at the invitation-only 7th World ... Vaccines in Clinical Trials. The meeting was held at ...
    ... Feb. 18, 2011 FUJIFILM Medical Systems ... footprint mobile application enabling remote access to ... as well as Macintosh- or Windows-based PCs.  Differentiated from ... quality, interactive three dimensional medical images in any platform ...
    Cached Medicine Technology:NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting 2NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting 3NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting 4NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting 5Fujifilm's Synapse® Mobility Extends Imaging Reach 2
    (Date:7/1/2015)... ... July 01, 2015 , ... ... and devices, today announced the opening of a new operational office in Zurich, ... that enables collaboration across all lines of business for organizations throughout the Swiss ...
    (Date:7/1/2015)... , ... July 01, 2015 , ... Nutritional Products International, ... nutritional and beauty products, recently attended the 2015 ECRM Diet, Vitamin & Sports Nutrition ... the retail industry. The ECRM trade show allows companies the chance to ...
    (Date:7/1/2015)... ... July 01, 2015 , ... RF Technologies, ... has partnered with WIU Crossroads School in safeguarding its staff and students with ... Education for Disruptive Youth) environment of Crossroads School heightens the potential for disorderly ...
    (Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... Foot ... Friske ( Clarksville Division ) participated in the annual Howard County Family Wellness Day ... promote healthy lifestyles, and included wellness screenings, activities for children, free workout demonstrations, and ...
    (Date:7/1/2015)... ... July 01, 2015 , ... First ... created a web-based resource where legal cannabis startups can interact with ... entrepreneurs and medical marijuana advocates looking to strategically enter and capitalize on growing ...
    Breaking Medicine News(10 mins):Health News:AvePoint Opens Office in Zurich to Meet Increasing Market Demand for Enterprise Collaboration Solutions in Switzerland 2Health News:AvePoint Opens Office in Zurich to Meet Increasing Market Demand for Enterprise Collaboration Solutions in Switzerland 3Health News:NPI Meets With Top Retail Figures at ECRM Conference 2Health News:WIU Crossroads School Chooses Help Alert Mobile Staff Duress Pendants from RF Technologies to Safeguard Staff and Students, De-escalate Altercations 2Health News:WIU Crossroads School Chooses Help Alert Mobile Staff Duress Pendants from RF Technologies to Safeguard Staff and Students, De-escalate Altercations 3Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Promotes Healthy Living 2Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Promotes Healthy Living 3Health News:First Harvest Financial Partners in Launch of Legal Medical Cannabis Documentary Initiative 2Health News:First Harvest Financial Partners in Launch of Legal Medical Cannabis Documentary Initiative 3
    ... small amount of smoke found in the environment can have ... a healthy school child. Even a small quantity of ... relying on the smoking habits of the parents and nears ... artery (located in the arm) function of 402 children, age ...
    ... old resident in New York, drank Boost Plus, a vitamin enriched ... ,When he woke up the next day, he had ... for medical advice and for treatment of the condition called severe ... is persistent, painful erection of the penis. Recurrent or severe episodes ...
    ... revealed that the prison population in England and Wales reached ... that there were fewer than 300 cells available for new ... cells to house prisoners in some areas of the country. ... of the BMAs Civil and Public Services Committee said: ...
    ... to iodine-containing contrast agents ,according to a recent study ... Center and C.S. Mott Childrens Hospital both in ... risk associated with iodine-containing contrast agents is allergic types ... hives or severe such as difficulty breathing or even ...
    ... a leading developer and manufacturer of a broad ... the launch of a new, higher power Smartlipo ... is intended for high-volume aesthetic laser practices, allowing ... procedure in about half the time as the ...
    ... Inc. (OTC Bulletin Board: IFLG), a leading provider of ... America, was identified today as one of the ... list of top companies by healthcare IT revenue. ... a 22 point jump over the previous year. InfoLogix's ...
    Cached Medicine News:Health News:Prison Healthcare Under Strain as Overcrowding Crisis Worsens, Warns BMA 2Health News:Cynosure Introduces Higher Power Smartlipo(TM) LaserBodySculpting Workstation 2Health News:InfoLogix, Inc. the Leading Healthcare Technology Company SaysHealthcare Informatics 2
    ... low density lipoprotein cholesterol (LDL-C) ... stable, ready-to-use reagent. Selective direct ... Excellent correlation with established reference ... Available with Calibrator: Trucal HDL/LDL ...
    Storage temperature: 2 - 8C, linearity: 0 - 25 mg/dL, expected value: 3.5 - 7.0 mg/dL. Available with calibrator and number of test 125....
    Storage temperature: 15 - 30C, linearity: 0 - 20 mg/dL, expected value: male: 3.0 - 7.0 mg/dL and female: 2.2 - 6.2 mg/dL. Available with calibrator and number of tests 125....
    For the quantitative determination of uric acid in serum....
    Medicine Products: